SASaadet Arsan

Saadet Arsan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saadet Arsan has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Tiered Genetic Diagnostic Approach in Newborns With Major Congenital Anomalies: Experience From a Tertiary NICU

    by Hatice Mutlu, Ece Eker, Yasemin Ezgi Köstekci, Ferhan Demirtaş, Doğan Kaymaz, Muhammed Doğukan Kalenderoğlu, Arzu Ay, Şule Altıner, Emel Okulu, Ömer Erdeve, et al.

    Background: Major congenital anomalies (MCAs) are a leading cause of neonatal morbidity and mortality and frequently reflect underlying chromosomal, copy number, or single‐gene defects. In neonates with multiple MCAs, early molecular diagnosis is critical but remains challenging due to phenotypic heterogeneity, overlapping developmental pathways, and limitations in selecting the most appropriate genetic test. Methods: This prospective study included 146 neonates with congenital anomalies who were referred for genetic consultation from a tertiary neonatal intensive care unit between April 2022 and May 2025. A major congenital anomaly was defined as a structural abnormality present at birth with significant medical, functional, or cosmetic consequences, while multiple congenital anomalies were defined as two or more major anomalies involving different organ systems. Clinical features were systematically annotated using Human Phenotype Ontology terms and classified according to organ system and embryological origin. A tiered diagnostic strategy was applied, including conventional cytogenetic analysis, chromosomal microarray analysis (CMA), whole‐exome sequencing (WES), and rapid‐WES (rWES) in selected critically ill neonates. Results: Cardiovascular anomalies were the most frequent (45.9%), and 88 of 146 neonates (60.3%) had two or more MCAs. Cytogenetic testing identified numerical chromosomal abnormalities in eight neonates. CMA detected pathogenic or likely pathogenic copy number variants in 6 of 65 tested cases (9.1%). In CMA‐negative patients, WES achieved a diagnostic yield of 41.4%, identifying variants in genes involved in multisystem developmental pathways. Rapid WES established definitive molecular diagnoses in two of three critically ill neonates within 72 h, directly influencing clinical management. Embryological analysis revealed recurrent co‐occurrence patterns, particularly cardiovascular–craniofacial and cardiovascular–genitourinary associations. Conclusion: A structured, tiered genomic approach enhances diagnostic yield in neonates with congenital anomalies. Integration of cytogenetics, CMA, and CNV‐aware exome sequencing provides a pragmatic and clinically actionable framework for molecular diagnosis in NICU settings and supports developmentally informed interpretation of complex phenotypes.

  • Open Access

    Balancing Overtreatment and Safety: Impact of 2023 Guideline Change on Antibiotic Use in Late Preterm Infants

    by Dogan Kaymaz, Deniz Uzun, Ferhan Demirtas, Yasemin Ezgi Kostekci, Emel Okulu, Omer Erdeve, Begum Atasay, Saadet Arsan

    Objective: To evaluate the impact of the 2023 national guideline revision, which increased the gestational age threshold for empirical antibiotic initiation from <34 to <35 weeks, on hospitalization and antibiotic exposure in infants born at 340/7-346/7 weeks. Materials and Methods: This single-center retrospective cohort study included all live-born infants at 340/7-346/7 weeks between April 2018 and September 2023. The same cohort was reassessed according to the 2018 and 2023 Turkish Neonatology Society’s national guidelines on the Diagnosis and Treatment of Neonatal Infections criteria. For each infant, neonatal intensive care unit (NICU) admission, empirical antibiotic use, and hospitalization duration were recalculated under both scenarios. Results: A total of 272 infants were included. Under the 2018 guideline, 68 infants (25.0%) required empirical antibiotics, whereas the 2023 guideline classified 197 infants (72.4%) as needing treatment, adding 129 newly eligible infants. Among these, 66 infants who had previously roomed-in required new NICU admission, increasing total admissions from 183 (67.3%) to 249 (91.5%). Median antibiotic duration increased from 0 days to 2 days, and median hospitalization increased from 5 to 6 days (both P < .001). None of the newly classified infants developed clinical or culture-proven early-onset neonatal sepsis (EONS). Conclusion: Raising the gestational age threshold to <35 weeks substantially increased empirical antibiotic use and NICU admissions without improving EONS detection. These findings highlight the need for more refined and clinically integrated risk-stratification strategies and underscore the broader implications of unnecessary antibiotic exposure, including increased NICU utilization, healthcare burden, and antimicrobial stewardship concerns.

  • Open Access

    Impact of the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline on Hospitalization Rates and Short-Term Outcomes: A Single-Center Study

    by Ferhan Demirtaş, Büşra Kütükçü, Yasemin Ezgi Köstekçi, Emel Okulu, Ömer Erdeve, Begüm Atasay, Saadet Arsan

    Objective: This study aimed to evaluate the impact of the revised 2022 American Academy of Pediatrics (AAP) guideline for hyperbilirubinemia on hospitalization rates and short-term outcomes. Materials and Methods: This retrospective observational study compared 2 periods, before (period 1: January 1-August 31, 2022) and after (period 2: September 1-December 31, 2022) implementation of the AAP 2022 guideline in a tertiary neonatal unit. Neonates born at ≥35 weeks’ gestational age who met phototherapy criteria were included. In period 2, infants who would have been hospitalized under the previous 2004 guideline but not under the new one were followed to assess the need for hospitalization and the occurrence of neurotoxicity. Results: The rate of hospitalization due to hyperbilirubinemia decreased from 23% (n = 95/409) in period 1 to 14% (n = 25/173) in period 2 (P = .017). When the new guideline was retrospectively applied, it was found that 58% (n = 55) of previously hospitalized patients in period 1 would not have required admission under the new criteria. In period 2, 37 neonates met the previous criteria, but only 25 were hospitalized under the new guideline; 2 of the 25 required rehospitalization. The remaining 12 newborns were followed as outpatients without developing neurotoxicity. Overall, 51% (n = 67) of newborns who met previous criteria did not meet the new hospitalization thresholds. Conclusion: The implementation of the AAP 2022 guideline was associated with a reduced risk of hospitalization without an increased risk of bilirubin-related neurotoxicity. Structured followup and individualized risk assessment remain essential for safe outpatient management. Cite this article as: Demirtaş F, Kütükçü B, Köstekçi YE, et al. Impact of the 2022 American Academy of Pediatrics hyperbilirubinemia guideline on hospitalization rates and short-term outcomes: A single-center study. Turk Arch Pediatr. 2025;60(5):531-535.


  • Open Access

    Correction to: School age outcomes of very premature infants randomized to cord milking versus early cord clamping at birth

    by Kamile Akyol Ozkara, Serdar Alan, Ezgi Ozalp Akin, Emel Okulu, Emine Bahar Bingoler Pekcici, Elcin Caglar, Omer Erdeve, Begüm Atasay, Saadet Arsan

  • Open Access

    School age outcomes of very premature infants randomized to cord milking versus early cord clamping at birth

    by Kamile Akyol Ozkara, Serdar Alan, Ezgi Ozalp Akin, Emel Okulu, Emine Bahar Bingoler Pekcici, Elcin Caglar, Omer Erdeve, Begüm Atasay, Saadet Arsan

    To evaluate the effect of intact cord milking (I-UCM) compared to immediate cord clamping (ICC) on neurodevelopmental outcomes at seven years of age in very preterm infants. This prospective single-blind cohort study included children who were previously participated in a randomized controlled trial comparing I-UCM and ICC. At about 7 years of age, participants were administered the Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) and the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV). A total of 31 children were included in the follow-up study. The mean age of participants was 6.4 ± 0.5 years. The mean gestational age at birth was 28.5 ± 1.7 weeks. There were no cases with grade ≥ 3 intraventriculary hemorrhage (IVH) in the present study cohort. Although the I-UCM group showed a trend toward higher median full-scale IQ, the difference was not statistically significant (p: 0.057). A significantly higher percentage of cases in the I-UCM group achived a full-scale IQ above 85 in the WISC-IV (p = 0.048). The mean of the "written language scaled score" subdomain among Vineland-II scores was found to be significantly higher in the I-UCM group. A significantly higher percentage of cases in the I-UCM group had a written language scaled score above 12 (p: 0.029). Conclusion: A comparison of I-UCM with ICC in preterm infants born at a mean age of 28 weeks and without severe IVH revealed that I-UCM did not result in long-term neurodevelopmental adverse outcomes. I-UCM even had positive effects in some subdomains of detailed neurodevelopmental tests. What is Known:• Compared to immediate cord clamping, umbilical cord milking improves the short-term postnatal outcomes of very preterm infants. There is a lack of robust data regarding the long-term neurodevelopmental effects of umbilical cord milking in preterm infants. What is New:• Among very preterm infants without severe intraventricular hemorrhage, intact umbilical cord milking was not associated with long-term adverse neurodevelopmental outcomes. Intact-umbilical cord milking even had positive effects in some subdomains of detailed neurodevelopmental tests.


  • Yenidoğan Yoğun Bakım Ünitesine Geçişte Bir Ara Basamak: Doğum Salonunda Kurulan Yenidoğan Ünitesinin Term ve Terme Yakın Yenidoğanlarda Solunum Sıkıntısı Nedenli Hastane Yatışları Üzerindeki Etkisinin Değerlendirilmesi

    by Yasemin Ezgi Köstekci, Aylin Ceren Akın, Ferhan Taş, Emel Okulu, Ömer Erdeve, Begüm Atasay, Saadet Arsan

    Amaç: Term ve terme yakın yenidoğanlarda doğum sonrası geçiş gecikmesine bağlı olarak gelişen solunum sıkıntısı, yenidoğan yoğun bakım ünitesi (YYBÜ) yatışlarının önemli bir nedenidir. Çalışmamızda ara basamak yapılanmanın, yenidoğanın geçici takipnesi (YGT) ve geçiş gecikmesi nedeniyle YYBÜ yatış ve pnömotoraks oranına etkisinin değerlendirilmesi amaçlanmıştır. Gereçler ve Yöntem: Hastanemiz doğum salonu içerisinde 1 Nisan 2021’de YYBÜ’ne kısa süreli yatışları azaltabilmek amacıyla, 4 yataklı ara basamak bir yenidoğan ünitesi kurulmuştur. Ünitede iki yenidoğan hemşiresi ve kıdemli iki pediatri asistanı görev almaktadır. ILCOR 2021 kılavuzu doğrultusunda solunum sıkıntısı nedeniyle nazal sürekli pozitif havayolu basıncı (nCPAP) ihtiyacı olan ≥34 haftada doğan yenidoğanlar, ara basamak kurulumu öncesi (Ocak 2020-Mart 2021=Dönem 1) ve sonrası (Nisan 2021-Aralık 2022=Dönem 2) olmak üzere iki dönemde perinatal, postnatal ve YYBÜ yatış özellikleri açısından retrospektif olarak değerlendirildi. Bulgular ve Sonuç: Dönem 1 ve Dönem 2’deki bebeklerin demografik özellikleri benzerdi (p>0.05). Dönem 1’de YYBÜ’nde nCPAP uygulanan bebeklerin %89’unda en az bir solunum sıkıntısı belirtisi mevcutken, Dönem 2’de 10. dakikadan sonra O2 satürasyon hedeflerine ulaşamadığı için daha erken nCPAP uygulanması nedeniyle, nCPAP uygulanan bebeklerin oranında artış, buna karşın hastane yatış oranlarında anlamlı azalma olduğu görüldü (p

  • Open Access

    Diagnostic challenge in a preterm infant with multiorgan failure: SARS-CoV-2 infection or neonatal multisystem inflammatory syndrome?

    by Yasemin Ezgi Köstekci, Alperen Aydın, Gül Arga, Mehmet Gökhan Ramoğlu, Emel Okulu, Halil Özdemir, Tayfun Uçar, Zeynep Ceren Karahan, Ömer Erdeve, Begüm Atasay, et al.


  • Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for

    by Fatma Tuba Eminoğlu, Merve Koç Yekedüz, Neslihan Doğulu, Ümmühan Öncül, Engin Köse, Emel Okulu, Ömer Erdeve, Begüm Atasay, Saadet Arsan

    Background: We aimed to assess symptoms, laboratory findings, and radiological abnormalities in patients diagnosed with inherited metabolic disorders (IMDs) in the neonatal intensive care unit. Methods: A total of 6,150 newborns treated in a third‐level neonatal intensive care unit between 2012 and 2020 in Turkey were screened, of which 195 consulted with a suspicion of metabolic disease based on their clinical, laboratory, or radiological findings were included in the present study. Results: The prevalence of IMDs in the patients was 1:94.6. Those consulted in the department of pediatric metabolism were divided into two groups, with the 65 diagnosed with IMDs assigned as Group I, and the 130 patients who were not diagnosed with IMDs as Group II. The most common IMDs were organic acidemias (29.23%) and urea cycle disorders (UCDs) (26.15%). The rates of consanguinity marriage (75.3% vs 37.6%, P < 0.001), siblings diagnosed with an IMD (27.6% vs 3.8%, P < 0.001), and sibling death (56.9% vs 14.6%, P < 0.001) were higher in Group I than in Group II. Hyperammonemia (61.5% vs 18.4%, P < 0.001) was the most common laboratory finding in Group I, and anemia (Group I 60.0% vs 43.0% P = 0.033), metabolic acidosis (53.8% vs 36.9%, P = 0.028) and respiratory alkalosis (16.9% vs 1.5%, P < 0.001) were all higher in Group I. Conclusions: This retrospective study found that the results of clinical findings and basic laboratory tests could be strong indicators of IMDs, although extensive newborn screening tests and advanced biochemical and genetic tests should be carried out for the diagnosis of IMDs in newborns.